WILLIAM D. PARKER
Neurology at Lee St, Charlottesville, VA
License number
Virginia 0101030975
Category
Neurology
Type
Neurology
Address
Address
Lee St, Charlottesville, VA 22908
Phone
(434) 924-0000
Professional information
William Parker - Charlottesville, VA
Work:
ACI-Costa Rica
Volunteer Martha Jefferson Hospital - Charlottesville, VA
Patient Care Assistant The Clean Machine Car Wash - Charlottesville, VA
Worker
Volunteer Martha Jefferson Hospital - Charlottesville, VA
Patient Care Assistant The Clean Machine Car Wash - Charlottesville, VA
Worker
William Davis Parker, Peoria IL
Specialties:
Neurology, Neurology with Special Qualifications in Child Neurology
Work:
Medical Service Plan
530 NE Glen Oak Ave, Peoria, IL 61603 UICOMP-U of I Medical Service Plan
420 NE Glen Oak Ave, Peoria, IL 61603 UVA Health Services Foundation
Rr 20, Charlottesville, VA 22903
530 NE Glen Oak Ave, Peoria, IL 61603 UICOMP-U of I Medical Service Plan
420 NE Glen Oak Ave, Peoria, IL 61603 UVA Health Services Foundation
Rr 20, Charlottesville, VA 22903
Education:
University of South Florida Health (1974)
William D Parker, Charlottesville VA
Specialties:
Neurologist
Address:
Lee St, Charlottesville, VA 22908
Methods For Detecting Mitochondrial Mutations Diagnostic For Alzheimer's Disease And Methods For Determining Heteroplasmy Of Mitochondrial Nucleic Acid
US Patent:
5976798, Nov 2, 1999
Filed:
Feb 28, 1997
Appl. No.:
8/810599
Inventors:
William Davis Parker - Charlottesville VA
Corinna Herrnstadt - San Diego CA
Soumitra Ghosh - San Diego CA
Eoin D. Fahy - San Diego CA
Corinna Herrnstadt - San Diego CA
Soumitra Ghosh - San Diego CA
Eoin D. Fahy - San Diego CA
Assignee:
Mitokor - San Diego CA
International Classification:
C12Q 168, C12P 1934, C07H 2104
US Classification:
435 6
Abstract:
The present invention relates to methods of detecting genetic mutations in mitochondrial cytochrome oxidase c genes that segregate with Alzheimer's Disease and methods for determining the amount of heteroplasmy of mitochondrial nucleic acid. The invention provides methods for detecting such mutations, as a diagnostic for Alzheimer's Disease, either before or after the onset of clinical symptoms.
Method Of Targeting Conjugate Molecules To Mitochondria
US Patent:
6171859, Jan 9, 2001
Filed:
Mar 30, 1995
Appl. No.:
8/413740
Inventors:
Corinna Herrnstadt - San Diego CA
William Davis Parker - Charlottesville VA
William Davis Parker - Charlottesville VA
Assignee:
Mitokor - San Diego CA
International Classification:
C12N 1564
US Classification:
435375
Abstract:
The present invention relates to genetic mutations in mitochondrial cytochrome c oxidase genes that segregate with Alzheimer's disease (AD). The invention provides methods for detecting such mutations, as a diagnostic for Alzheimer's Disease, either before or after the onset of clinical symptoms. The invention further provides treatment of cytochrome c oxidase dysfunction.